Clinical trials
Clinical trials
See all stories related to clinical trials at Johnson & Johnson.
Have questions about participating in a COVID-19 vaccine clinical trial? A doctor overseeing a study helps answer them
Njira Lugogo, M.D., is a pulmonologist at the University of Michigan who is leading a clinical study of an investigational COVID-19 vaccine candidate. She helps answer common questions people may have about the process, from what people over 60 need to know to how participants are being kept safe during the pandemic.
The 5 stages of COVID-19 vaccine development: What you need to know about how a clinical trial works
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
“We have a health disparities problem in America": Meet a woman on a mission to improve healthcare for black women
The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this urgent crisis.
“AIDS won’t stop for COVID-19": Meet 3 inspiring women who are as committed as ever to making HIV history
For World AIDS Day, three attendees of the virtual 2020 International AIDS Society Conference, including activist and actress Laverne Cox, talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.
“What COVID-19 has taught me": 7 Johnson & Johnson researchers reveal lessons they’ve learned from the pandemic
From scientists working on a potential vaccine to medically trained employees who mobilized to the front lines to help treat patients, these men and women share what most resonates for them about the unique and devastating virus, both professionally and personally.
“No single entity can solve this challenge alone": An honest conversation about racial inequity
Johnson & Johnson’s Chief Communication Officer Michael Sneed sits down to have a frank discussion about what we need to do to help build a more equitable healthcare system—and society.
Clinical trials 2.0: 5 ways Johnson & Johnson is helping revamp—and revolutionize—how they’re conducted
From working to broaden the pool of patients trials have traditionally studied to finding ways for people to participate from the comforts of home, we look at how the company is reinventing clinical trials in truly forward-thinking ways.
What really happens to your patient data? A chief medical officer explains
With health insurance enrollment season in full swing, you may be researching which plan to get—and signing those data disclosure forms. But have you ever wondered how some of that info is used once you sign on the dotted line?
“I’ve been living with advanced prostate cancer for almost 20 years": One man shares his treatment journey
Have you been putting off getting your prostate checked? Men’s Health Month is the perfect time to tackle this important medical to-do. Just ask Ron Scolamiero, who was surprised by a prostate cancer diagnosis at 54. He shares his story of resilience.
5 ways one company is working to boost the health of the African-American community
From partnering with the Black AIDS Institute to reduce HIV infection rates to improving representation in clinical trials, learn how Johnson & Johnson has made it a mission to help address disparities in healthcare.